<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    ConforMIS, Inc.

    ConforMIS, Inc.

    ConforMIS is a medical technology company that uses its proprietary iFitÂŽ Image-t...

    ConforMIS is a medical technology company that ...

    Filing Type:    PU
    Participant Assistive Products

    Participant Assistive Products

    We make affordable assistive products, starting with a groundbreaking supportive w...

    We make affordable assistive products, starting...

    Amount Raised:    $211,262.00
    Fundraising Status:    EC
    Filing Type:    CF
    OpGen, Inc.

    OpGen, Inc.

    OpGen, Inc. is a precision medicine company harnessing the power of molecular diag...

    OpGen, Inc. is a precision medicine company har...

    Filing Type:    PU
    ImmuCell Corporation

    ImmuCell Corporation

    ImmuCell Corporation’s (Nasdaq: ICCC) purpose is to create scientifically-proven...

    ImmuCell Corporation’s (Nasdaq: ICCC) purpose...

    Filing Type:    PU
    Personalis, Inc.

    Personalis, Inc.

    Personalis, Inc. is a growing cancer genomics company transforming the development...

    Personalis, Inc. is a growing cancer genomics c...

    Filing Type:    PU
    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    Smilelove LLC

    Smilelove LLC

    Smilelove offers clear aligner treatments direct-to-consumer: no expensive appoint...

    Smilelove offers clear aligner treatments direc...

    Amount Raised:    $704,405.00
    Fundraising Status:    SD
    Filing Type:    CF
    Fisher Wallace Laboratories, Inc.

    Fisher Wallace Laboratories, Inc.

    Fisher Wallace manufactures and markets wearable medical devices for the treatment...

    Fisher Wallace manufactures and markets wearabl...

    Amount Raised:    $670,653.00
    Fundraising Status:    EC
    Filing Type:    CF
    Lantheus Holdings, Inc.

    Lantheus Holdings, Inc.

    Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (â...

    Lantheus Holdings, Inc. is the parent company o...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.